Evidence map›Paper›PMID 36836147›Full record

ReviewJournal of clinical medicine2023

Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways.

Ciro Mauro, Valentina Capone, Rosangela Cocchia, Filippo Cademartiri, Ferdinando Riccardi, Michele Arcopinto, Maie Alshahid, Kashif Anwar, Mariano Carafa, Andreina Carbone and 21 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Role of Troponins in CardioOncology.Current treatment options in oncology · 2026
    Review
  2. Review
  3. Article
  4. Neoadjuvant chemotherapy and perioperative cardiotoxicity.Journal of anesthesia and translational medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Ciro MauroCardiology Division, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Valentina CaponeCardiology Division, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.ORCID 0000-0002-0080-9948
Rosangela CocchiaCardiology Division, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Filippo CademartiriDepartment of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, Via Moruzzi, 1, 56124 Pisa, Italy.ORCID 0000-0002-0579-3279
Ferdinando RiccardiOncology Unit, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Michele ArcopintoDepartment of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.
Maie AlshahidThe Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11564, Saudi Arabia.
Kashif AnwarThe Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11564, Saudi Arabia.
Mariano CarafaEmergency Medicine Division, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Andreina CarboneUnit of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, 80131 Naples, Italy.ORCID 0000-0002-2190-7010
Rossana CastaldoIRCCS SYNLAB SDN, Via Emanuele Gianturco, 113, 80143 Naples, Italy.ORCID 0000-0003-4143-1678
Salvatore ChianeseCardiology Division, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Giulia CrisciDepartment of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.
Roberta D'AssanteDepartment of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.ORCID 0000-0001-6729-374X
Mariarosaria De LucaDepartment of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.ORCID 0000-0002-6727-5725
Monica FranzeseIRCCS SYNLAB SDN, Via Emanuele Gianturco, 113, 80143 Naples, Italy.ORCID 0000-0002-6490-7694
Domenico GalzeranoThe Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11564, Saudi Arabia.ORCID 0000-0002-9682-3815
Vincenzo MaffeiPost Operative Intensive Care Division, Antonio Cardarelli Hospital, 9, 80131 Naples, Italy.
Alberto Maria MarraDepartment of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.
Alfredo MazzaUnit of Cardiology, Camerino Hospital, 62032 Macerata, Italy.
Brigida RanieriIRCCS SYNLAB SDN, Via Emanuele Gianturco, 113, 80143 Naples, Italy.ORCID 0000-0003-4880-5679
Anna D'AgostinoIRCCS SYNLAB SDN, Via Emanuele Gianturco, 113, 80143 Naples, Italy.ORCID 0000-0002-1394-4786
Salvatore RegaDepartment of Public Health, University Federico II of Naples, Via Sergio Pansini, 5, 80131 Naples, Italy.
Luigia RomanoDepartment of General and Emergency Radiology, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Sarah ScagliariniOncology Unit, Antonio Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.ORCID 0000-0001-5814-2296
Chiara SepeTechnical Nursing and Rehabilitation Service (SITR) Department, Cardarelli Hospital, 80131 Naples, Italy.
Olga VrizThe Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh 11564, Saudi Arabia.
Raffaele IzzoDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Via Sergio Pansini, 5, 80131 Naples, Italy.ORCID 0000-0002-0308-2836
Antonio CittadiniDepartment of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.
Eduardo BossoneDepartment of Public Health, University Federico II of Naples, Via Sergio Pansini, 5, 80131 Naples, Italy.ORCID 0000-0003-2769-9950
Andrea SalzanoIRCCS SYNLAB SDN, Via Emanuele Gianturco, 113, 80143 Naples, Italy.ORCID 0000-0003-2352-2103

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection and treatment of cancer have led to a noticeable reduction in both mortality and morbidity. However, chemotherapy and radiotherapy could exert cardiovascular (CV) side effects, impacting survival and quality of life, independent of the oncologic prognosis. In this regard, a high clinical index of suspicion is required by the multidisciplinary care team in order to trigger specific laboratory tests (namely natriuretic peptides and high-sensitivity cardiac troponin) and appropriate imaging techniques (transthoracic echocardiography along with cardiac magnetic resonance, cardiac computed tomography, and nuclear testing (if clinically indicated)), leading to timely diagnosis. In the near future, we do expect a more tailored approach to patient care within the respective community along with the widespread implementation of digital health tools.

Indexed as

cancer therapy-related cardiovascular toxicitycardio-oncologychemotherapy

Identifiers

PMID36836147
PMCPMC9962102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.